(Q28371706)

1

0 references

X M Liu

2

0 references

W Kreis

3

0 references

D R Budman

Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2

4

0 references

language of work or name

English

0 references

publication date

1 May 1998

0 references

published in

Biochemical Pharmacology

0 references

volume

55

0 references

issue

9

0 references

page(s)

1427-33

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Clinical pharmacokinetics of estramustine phosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

The hydrolysis of estramustine phosphate; in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Synergism between androgens and protein kinase-C on androgen-regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Induction of differentiation and down-regulation of c-myb gene expression in ML-1 human myeloblastic leukemia cells by the clinically effective anti-leukemia agent meisoindigo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

The steroid and thyroid hormone receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6

Hydroxyflutamide may not always be a pure antiandrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900657-6